PA
KYNB

Perceptive Advisors’s Kyntra Bio KYNB Stock Holding History

Perceptive Advisors’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-372
Closed -$506K – 111
2019
Q1 		$506K Buy
+372
New +$505K 0.01% 92
2017
Q4 		– Sell
-344
Closed -$462K – 139
2017
Q3 		$462K Buy
+344
New +$362K 0.02% 125

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Perceptive Advisors's KYNB Position: Q2 2019 in Review

Perceptive Advisors sold out of Kyntra Bio (KYNB) in Q2 2019, closing a stake of 372 shares — an estimated $506K sold.

Perceptive Advisors first reported a position in KYNB in Q3 2017 and held it in 2 quarters. The position peaked at $506K in Q1 2019. 190 funds tracked by Wall St. Rank hold KYNB as of Q2 2019.

  • Perceptive Advisors reported no remaining Kyntra Bio position as of Q2 2019 after selling out during the quarter.
  • Perceptive Advisors sold 372 Kyntra Bio shares in Q2 2019, an estimated $506K.
  • Perceptive Advisors first reported a position in Kyntra Bio in Q3 2017 and held it in 2 quarters.
  • Perceptive Advisors's Kyntra Bio position peaked at $506K in Q1 2019.
  • 190 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2019.

Based on Perceptive Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.